Mankind Pharma

2,348.45
-16.10
(-0.68%)
Market Cap
96,889.27 Cr
EPS
47.75
PE Ratio
47.77
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
3,054.80
52 Week low
1,901.05
PB Ratio
7.19
Debt to Equity
0.02
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from14 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy71.43 %
71.43 %
Hold14.29 %
14.29 %
Sell14.29 %
14.29 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,669.30 4,00,520.99 34.13 49,887.20 12.06 9,648 13.77 37.74
5,978.30 1,58,705.08 76.14 8,184.00 0.89 1,600 64.53 51.57
1,479.70 1,19,502.65 23.70 26,520.70 14.17 4,155 47.38 51.15
3,095.95 1,04,781.02 56.64 10,785.70 11.59 1,656 13.54 45.77
1,170.95 97,705.34 18.09 28,905.40 12.36 5,578 1.69 30.83
2,348.45 96,889.27 47.77 10,615.60 19.57 1,942 -16.38 39.42
899.65 90,525.84 19.78 19,831.50 13.82 3,831 29.92 36.77
1,977.50 90,213.07 31.46 20,141.50 19.94 1,936 38.82 38.83
1,121.25 65,122.38 18.72 29,559.20 17.55 3,169 -10.04 42.81
29,429.65 62,535.95 47.37 6,097.20 10.80 1,201 16.01 61.56
Growth Rate
Revenue Growth
19.57 %
Net Income Growth
48.26 %
Cash Flow Change
18.70 %
ROE
18.04 %
ROCE
13.14 %
EBITDA Margin (Avg.)
16.05 %

Quarterly Financial Results

Quarterly Financials
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
1,764
2,200
2,457
2,130
2,103
2,642
2,772
2,682
2,536
2,998
3,189
3,311
Expenses
1,441
1,724
1,835
1,654
1,636
1,924
2,025
2,000
1,850
2,212
2,227
2,400
EBITDA
323
476
622
477
467
718
746
681
686
786
962
911
Operating Profit %
17 %
21 %
24 %
21 %
20 %
25 %
25 %
23 %
24 %
24 %
28 %
26 %
Depreciation
47
78
79
85
85
87
97
110
105
108
106
192
Interest
13
16
10
13
5
6
9
9
9
11
7
221
Profit Before Tax
263
382
533
379
377
625
641
562
572
668
849
497
Tax
70
84
110
83
84
130
130
103
95
125
190
113
Net Profit
193
298
423
296
294
494
511
460
477
543
659
385
EPS in ₹
4.74
7.30
10.48
7.09
7.13
12.15
12.51
11.33
11.76
13.39
16.31
9.45

Balance Sheet

Balance Sheet
2022
2023
2024
Total Assets
9,148
9,715
11,963
Fixed Assets
3,588
4,251
4,545
Current Assets
4,407
4,328
6,568
Capital Work in Progress
702
550
282
Investments
1,110
1,346
2,568
Other Assets
3,749
3,568
4,568
Total Liabilities
9,148
9,715
11,963
Current Liabilities
2,624
1,863
2,120
Non Current Liabilities
208
229
268
Total Equity
6,316
7,623
9,576
Reserve & Surplus
6,115
7,395
9,323
Share Capital
40
40
40

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
Net Cash Flow
103
-92
156
22
77
Investing Activities
-436
-1,222
-1,369
-1,052
-2,081
Operating Activities
1,070
1,137
920
1,813
2,152
Financing Activities
-531
-8
605
-740
5

Share Holding

% Holding
Sept 2022
Mar 2023
May 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
79.00 %
76.50 %
76.50 %
76.50 %
76.50 %
76.50 %
74.88 %
74.87 %
74.87 %
72.71 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
9.87 %
11.58 %
12.37 %
13.34 %
DIIs
0.00 %
2.64 %
2.64 %
4.64 %
4.39 %
9.49 %
11.14 %
9.95 %
9.90 %
11.06 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
4.15 %
4.15 %
1.02 %
1.11 %
1.14 %
1.22 %
1.46 %
1.55 %
1.60 %
Others
21.00 %
16.71 %
16.71 %
17.83 %
18.00 %
12.87 %
2.89 %
2.15 %
1.31 %
1.30 %
No of Share Holders
17
4,02,322
4,02,322
1,31,918
1,34,731
1,27,449
1,35,116
1,53,450
1,63,854
1,72,431

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2 hours ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2 hours ago
Announcement under Regulation 30 (LODR)-Change in Directorate
2 days ago
Final Update On Stake Sale Of Mahananda Spa And Resorts Private Limited
8 days ago
Announcement under Regulation 30 (LODR)-Diversification / Disinvestment
10 days ago
Board Meeting Outcome for Mankind Pharma Limited Has Informed The Exchange Regarding Sale Of Entire Stake In Mahananda Spa And Resorts Private Limited
10 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 06, 2025, 15:24
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 06, 2025, 15:18
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Feb 04, 2025, 21:40
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Jan 30, 2025, 15:12
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Jan 24, 2025, 17:10
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Jan 24, 2025, 15:19
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jan 24, 2025, 15:09
Announcement under Regulation 30 (LODR)-Investor Presentation
Jan 23, 2025, 19:54
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Jan 23, 2025, 19:52
Statement Under Regulation 32 Of The Listing Regulations.
Jan 23, 2025, 19:37
Integrated Filing (Financial)
Jan 23, 2025, 19:26
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. January 23 2025.
Jan 23, 2025, 19:18
Intimation Regarding Redemption Of Commercial Paper
Jan 16, 2025, 17:17
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Jan 15, 2025, 09:23
Commercial Paper-Quarterly Certificate December 2024
Jan 14, 2025, 18:56
Intimation Of Record Date For Redemption Of Commercial Paper Issued By The Company
Jan 14, 2025, 18:51
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 14, 2025, 17:20
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 And 50 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Jan 13, 2025, 15:52
Announcement Under Regulation 30 Of SEBI LODR
Jan 08, 2025, 16:43
Appointment of Company Secretary and Compliance Officer
Jan 08, 2025, 16:36
Announcement under Regulation 30 (LODR)-Cessation
Jan 08, 2025, 16:31
Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. January 8 2025
Jan 08, 2025, 16:22
Creation Of Pledge On The Shares Of Bharat Serums And Vaccines Limited
Jan 07, 2025, 19:43
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 06, 2025, 13:54
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) 2015
Dec 28, 2024, 14:36
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Dec 27, 2024, 11:43
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Dec 23, 2024, 17:40

Technical Indicators

RSI(14)
Neutral
39.42
ATR(14)
Less Volatile
97.07
STOCH(9,6)
Neutral
23.43
STOCH RSI(14)
Neutral
22.38
MACD(12,26)
Bearish
-4.84
ADX(14)
Weak Trend
15.45
UO(9)
Bearish
46.41
ROC(12)
Downtrend But Slowing Down
-7.46
WillR(14)
Oversold
-83.36